The stethoscope, one of the most iconic symbols of medicine, was invented over 200 years ago. Today, artificial intelligence is revolutionizing this essential tool, empowering doctors to detect cardiac disease at its earliest stages with greater precision during routine visits. The podcast episode features Demilade Adedinsewo, M.B., Ch.B., cardiologist at Mayo Clinic and Jason Bellet, co-founder of Eko Health.

Get the latest health information from Mayo Clinic's experts, subscribe to Mayo Clinic’s newsletter for free today: [insert link to preference center]

Researchers are pioneering innovative ways to restore voice to those who have lost it, leveraging advancements in transplant surgery and 3D printing. Featured experts include David Lott, M.D., associate director of Mayo Clinic's Center for Regenerative Biotherapeutics and chair of the Department of Otolaryngology and Marshall Strome, M.D., otolaryngologist, professor, and chair emeritus of the Cleveland Clinic Head and Neck Institute.

Imagine knowing your risk for disease long before symptoms appear. With early detection and targeted interventions, this knowledge could transform how complex healthcare challenges are addressed. Researchers are now leveraging genetic data to enhance disease risk prediction through an innovative tool known as a polygenic risk score. The episode features Victor Ortega, M.D., Ph.D., associate director of the Mayo Clinic Center for Individualized Medicine and Louise Wain, Ph.D., professor of respiratory research, University of Leicester.

Hollywood's cutting-edge technology is revolutionizing medical education, bridging the gap between classroom learning and clinical practice. Learn how VR is helping students explore 3D models of the human body, practice complex procedures in a risk-free environment, and simulate patient encounters. Through immersive digital scenarios, medical students are refining their skills and gaining hands-on experience for real-world challenges. Featured experts include Matthew Hoerth, M.D., medical director of the Multidisciplinary Simulation Center at Mayo Clinic in Arizona and Dan Munnerley, executive director of the Next Lab at Arizona State University.

Have you ever wondered how artificial intelligence is helping solve medical problems? Or how medical research is making it easier to predict your genetic risks for disease? Season 2 of Tomorrow’s Cure brings together experts from Mayo Clinic and other leading organizations to share how they use innovative thinking in their pursuit of answers for patients. What they describe may sound futuristic but listen and you will find out, Tomorrow’s Cure is already here.

Healthcare is changing rapidly. Tomorrow’s cure is already here today. How do top medical educational institutes prepare and equip the workforce for the fast-changing healthcare landscape? Find out from our featured experts: Dr. Fredric Meyer, Executive Dean of Education, Enterprise Chair of Neurological Surgery at Mayo Clinic; and Dr. James Stoller, Chair of Education Institute at Cleveland Clinic.

The first mixed-reality-navigated shoulder replacement surgery in the U.S. took place in early 2024. Specialized technologies were used to create a customized life-size hologram of the patient’s joint and plan the position of the replacement implants. Listen to how mixed reality improves surgical precision and may reduce complications and improve patient recovery. Featured experts include the surgeon who performed this very first surgery: Dr. Sanchez-Sotelo, Division Chair Shoulder & Elbow Surgery at Mayo Clinic; and ​​​​Jean Chaoui, VP of Clinical Applications and Solutions, Digital, Robotics and Enabling Technologies at Stryker.

How is AI used to improve all parts of the organ-transplant process? AI is powerful in detecting potential impacts of early interventions to delay or prevent organ failure and the need for organ replacement therapies. Press play to hear more about research efforts to use AI to detect organ failure earlier. Featured experts are Dr. Rohan Goswami, Transplant Cardiologist and Director of Heart Transplant Research and Innovation at Mayo Clinic; and Javier Echenique, Co-founder and Chief Executive Officer at GPx, a healthcare technology company.